SGLT-2 inhibitor prescription at hospital discharge in heart disease T2DM patients was safe and well tolerated, moreover it was associated with a reduction in all-cause and cardiovascular deaths during follow-up. Here, SLC5A2 is linked to type 2 diabetes mellitus.